Ibritumomab Tiuxetan and Lyderm
Determining the interaction of Ibritumomab Tiuxetan and Lyderm and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab
Generic Name: fluocinonide topical
Brand name: Fluocinonide-E, Fluovix, Vanos, Lidex, Licon, Lidex-E, Dermacin, Fluex
Synonyms: Fluocinonide topical, Fluocinonide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Tiuxetan-Lydia E. Pinkham
- Ibritumomab Tiuxetan-Lyme disease vaccine (recombinant ospa) Intramuscular
- Ibritumomab Tiuxetan-Lymepak
- Ibritumomab Tiuxetan-Lymphocyte immune globulin, anti-thymocyte equine
- Ibritumomab Tiuxetan-Lymphoseek
- Ibritumomab Tiuxetan-Lynparza
- Lyderm-Ibrutinib
- Lyderm-Ibrutinib Capsules
- Lyderm-Ibrutinib Tablets
- Lyderm-Ibu
- Lyderm-IBU Tablets
- Lyderm-Ibu-2